Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.

about

Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.

Item

http://www.wikidata.org/entity/Q41112838

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Visual and Anatomical Outcomes ...... tral Serous Chorioretinopathy.

@en

type

Item

label

Visual and Anatomical Outcomes ...... tral Serous Chorioretinopathy.

@en

prefLabel

Visual and Anatomical Outcomes ...... tral Serous Chorioretinopathy.

@en

P1476

Visual and Anatomical Outcomes ...... tral Serous Chorioretinopathy.

@en

P2093

Abbas Habibi

http://www.w3.org/2001/XMLSchema#string

Acieh Eshaghi

http://www.w3.org/2001/XMLSchema#string

Anahita Amirsardari

http://www.w3.org/2001/XMLSchema#string

Kaveh Abri Aghdam

http://www.w3.org/2001/XMLSchema#string

Shohreh Bakhti

http://www.w3.org/2001/XMLSchema#string

P2860

Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interi

Aldosterone receptor antagonists: effective but often forgotten.

Oral eplerenone for the management of chronic central serous chorioretinopathy.

Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.

Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.

Central serous chorioretinopathy: what we have learnt so far.

Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.

The multifaceted mineralocorticoid receptor

Therapeutic benefit of melatonin in refractory central serous chorioretinopathy

P304

281-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JOVR.JOVR_139_16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Khalil Ghasemi Falavarjani

Kaveh Abri Aghdam

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28791061

http://www.w3.org/2001/XMLSchema#string

P932

5525497

http://www.w3.org/2001/XMLSchema#string